Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Frontal Fibrosing Alopecia in men is often missed and can come with symptoms like facial bumps and hair loss on eyebrows and limbs.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

Woman has discoid lupus, frontal fibrosing, and androgenetic alopecia.

Low-dose oral minoxidil improved or stabilized hair loss in some patients, but higher doses may be needed for significant effects.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Chemotherapy caused hair loss with specific patterns, but most patients had hair regrowth after treatment, while some had lasting hair loss.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

The review concludes that accurate diagnosis of different types of hair loss requires proper biopsy techniques and understanding the hair growth cycle and underlying causes.

The meeting focused on understanding, diagnosing, and finding treatments for irreversible hair loss diseases.

Stem cell technologies and regenerative medicine, including platelet-rich plasma, show promise for hair restoration in treating hair loss, but more research is needed.

Treatments for common hair loss include minoxidil, finasteride, and hair transplantation.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Platelet-rich plasma (PRP) treatment has been found effective in promoting hair growth for alopecia patients, with minimal side effects like temporary pain and redness.

Topical cetirizine improves hair density and thickness in androgenetic alopecia, but more research is needed.

Most hair loss disorders can be accurately diagnosed and treated in an outpatient setting.

Endoxan often causes hair loss, which usually starts in the third week of treatment.

Personalized treatment with inhibitors, minoxidil, and laser therapy helps hair loss.

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.

A rare ITGB6 gene variant causes intellectual disability, hair loss, and dental issues.

Balding hair follicle cells are smaller, grow less well, and need more effort to culture than non-balding cells.

Wnt/β-catenin and TGF-β pathways affect hair loss, and activating Wnt/β-catenin could be a potential treatment.

Finasteride and low-dose dutasteride combo improves hair growth and reduces hair loss with no major side effects.

Hormonal changes during and after pregnancy can cause hair growth changes and hair loss, with treatments available for some conditions.

Hair from balding and non-balding areas regrows similarly on mice.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

Latanoprost works better for hair growth, and combining it with betamethasone valerate is most effective.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.